Q4 2024 Results February 6, 2025 Not for Product Promotional Use Forward Looking Statements and Non-GAAP Financial Information This presentation contains statements about Bristol-Myers Squibb Company's (the "Company") future financial results, plans, business development strategy, anticipated clinical trials, results and regulatory approvals that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. All statements that ar ...

February 6, 2025 APTIV Fourth Quarter 2024 Earnings Call Forward-Looking Statements This presentation, as well as other statements made by Aptiv PLC (the "Company"), contain forward-looking statements that reflect, when made, the Company's current views with respect to current events, certain investments and acquisitions and financial performance. Such forward-looking statements are subject to many risks, uncertainties and factors relating to the Company's operations and business environment, which may caus ...

Forward-Looking Statements Earnings Conference Call Fiscal Q1 2025 February 6, 2025 Safe Harbor Statement Regarding Forward-Looking Statements Today's topics: Strategic Priorities Dev Kurdikar Chief Executive Officer Jake Elguicze Chief Financial Officer Guidance Q&A Pravesh Khandelwal This presentation contains express or implied "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995 and other securities laws. These forward-looking statements concern ou ...

Societe Generale Group Results Fourth quarter and full year 2024 results Disclaimer The financial information on Societe Generale for its fourth quarter and full year 2024 financial results comprises this presentation and a dedicated press release which are available on the website: https://investors.societegenerale.com/en. This presentation contains forward-looking statements relating to the targets and strategies of the Societe Generale Group. These forward- looking statements are based on a series of ass ...

Advancing the world of healthTM Caution Concerning Forward-looking Statements This presentation and accompanying webcast contain certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, earnings per share, leverage targets and capital deployment, and the contemplated separation of BD's Biosciences and Diagnostic Solutions business, including, but not limited to, ...

4Q 2024 Earnings Conference Call February 6, 2025 Safe Harbor Regarding Forward-Looking Statements Forward-Looking Statements This presentation contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and ...

EARNINGS RESULTS & OPERATING INFORMATION FOURTH QUARTER 2024 Executive Summary Our portfolio is located in the premier coastal submarkets of Los Angeles and Honolulu. Our In-Service Portfolio includes 17.5 million square feet of Class A office properties and 4,391 apartment units, and we have an additional 456,000 square feet of Class A office and 712 apartment units in our Development Portfolio. During 2024, we made significant progress on several key growth initiatives. We purchased an office property and ...

Q1 FY2025 Investor Presentation 2.5.2025 Key Themes Niko Lahanas, CEO Financials, Segments & Outlook Brad Smith, CFO Management Q&A Niko Lahanas, Brad Smith, J.D. Walker, John Hanson Q1 FY25 Investor Presentation 2 Niko Lahanas CEO Forward-looking Statements Q1 FY25 Investor Presentation The statements contained in this presentation which are not historical facts, including statements concerning productivity initiatives and earnings guidance for fiscal 2025, are forward-looking statements that are subject t ...

Exhibit 99.3 Fourth Quarter 2024 Financial Results and Highlights February 5, 2025 © 2025 Cognizant Forward-looking statements This earnings supplement includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which is necessarily subject to risks, uncertainties and assumptions as to future events that may not prove to be accurate. These statements include, but are not limited to, ex ...

CSG Q4 & Full Year 2024 Earnings Presentation Brian Shepherd CEO & President Hai Tran CFO Safe Harbor Forward-Looking Statements + Disclaimers This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will ...